299660 — Cellid Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Cellid Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,069	19,939	18,644	15,023	9,017
Net Total Accounts Receivable
Net Total Receivables	175	204	695	213	630
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12,975	20,808	20,978	16,874	11,450
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	21,800	22,258	20,665	40,348	44,730
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	49,400	58,256	45,857	63,922	76,086
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,044	1,846	20,539	10,325	4,943
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	2,104	19,496	23,419	23,427	24,883
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	47,296	38,761	22,439	40,495	51,203
Total Liabilities & Shareholders' Equity	49,400	58,256	45,857	63,922	76,086
Total Common Shares Outstanding